Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boundless Bio, Inc.
OncoC4, Inc.
SOLTI Breast Cancer Research Group
Sarcoma Oncology Research Center, LLC
Cybrexa Therapeutics